# Corticosteroid Prophylaxis on the Cardiopulmonary Bypass-Induced Systemic Inflammatory Response

> **NCT01296074** · NA · COMPLETED · sponsor: **Beijing Anzhen Hospital** · enrollment: 30 (actual)

## Conditions studied

- Heart Valve Diseases
- Systemic Inflammatory Response Syndrome

## Interventions

- **DRUG:** Corticosteroid

## Key facts

- **NCT ID:** NCT01296074
- **Lead sponsor:** Beijing Anzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2011-04
- **Final completion:** 2011-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01296074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01296074, "Corticosteroid Prophylaxis on the Cardiopulmonary Bypass-Induced Systemic Inflammatory Response". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01296074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*